Latest

New 2017 ACC/AHA Hypertension Guidelines, At-a-GlanceA shift to earlier intervention and emphasis on basics like proper BP measurement and intensive lifestyle change are the key revisions.
Evolocumab Impact Significant in Patients with PADLowering LDL-C levels in FOURIER trial patients with PAD had a significant impact on both MACE and MALE.
Selexipag Delays PAH Progression in Patients with Connective Tissue DiseaseResults of a subgroup analysis from the GRIPHON trial are promising for a hard-to-treat population.
New Biomarker Could Improve ARDS, AHF DiagnosisA biomarker of myocardial strain and inflammation may be able to discriminate between two similar pulmonary emergencies.
Quiz: 2017 ACC/AHA/HFSA Update to 2013 HF GuidelinesTest your recall of the most recent amendments to the heart failure guidelines on prevention, treatment of hypertension, and comorbidities.
Methamphetamine-associated PAH: First Prospective Cohort StudyMethamphetamine abuse is on a steady rise in the US. A new study highlights the nature and dangers of Meth-PAH.
Hypertension, Target Organ Injury, and the BrainQuiz: Are you current on early evidence that suggests hypertension is a risk factor for Alzheimer disease and other dementias? .
Dose-adjusted DOACs vs Warfarin: Overview of EfficacyPatients who require dose adjustment when taking direct oral anticoagulants have not been well studied. This large study is a good start.
No Difference in CV Outcomes with Statin plus Add-on vs Statin AloneThe HIJ-PROPER study found intensive LDL-lowering therapy added no additional therapeutic value in patients with ACS.
Hellenic Heart Failure Study: Impact of Mediterranean Diet on Recurrent ACSResults of this study suggest a role for the anti-inflammatory diet in secondary prevention.